Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis

Qianqian Guo,Kunimaro Furuta,Shahidul Islam,Nunzia Caporarello,Enis Kostallari,Kobe Dielis,Daniel J. Tschumperlin,Petra Hirsova,Samar H. Ibrahim
DOI: https://doi.org/10.3389/fimmu.2022.983255
IF: 7.3
2022-08-25
Frontiers in Immunology
Abstract:Background During liver injury, liver sinusoidal endothelial cells (LSECs) dysfunction and capillarization promote liver fibrosis. We have previously reported that the LSEC vascular cell adhesion molecule 1 (VCAM1) plays a key role in liver inflammation in nonalcoholic steatohepatitis (NASH) and we now aim to uncover its role in LSEC capillarization and liver fibrosis. Methods Wild-type C57BL/6J mice were fed either chow or high fat, fructose and cholesterol diet to induce NASH and treated with either anti-VCAM1 neutralizing antibody or control isotype antibody. Inducible endothelial cell-specific Vcam1 deleted mice ( Vcam1 Δend ) and control mice ( Vcam1 fl/fl ) were fed choline-deficient high-fat diet (CD-HFD) to induce NASH or injected with carbon tetrachloride to induce liver fibrosis. LSECs isolated from Vcam1 fl/fl or Vcam1 Δend and hepatic stellate cells (HSCs) isolated from wild-type mice were cocultured in a 3-D system or a μ-Slide 2 well co-culture system. Results Immunostaining for Lyve1 (marker of differentiated LSECs) was reduced in Vcam1 fl/fl mice and restored in Vcam1 Δend mice in both NASH and liver fibrosis models. Co-immunostaining showed increased α-smooth muscle actin in the livers of Vcam1 fl/fl mice in areas lacking Lyve1. Furthermore, scanning electron microscopy showed reduced LSEC fenestrae in the Vcam1 fl/fl mice but not Vcam1 Δend mice in both injury models, suggesting that VCAM1 promotes LSEC capillarization during liver injury. HSCs profibrogenic markers were reduced when cocultured with LSECs from CD-HFD fed Vcam1 Δend mice compared to Vcam1 fl/fl mice. Furthermore, recombinant VCAM1 activated the Yes-associated protein 1 pathway and induced a fibrogenic phenotype in HSCs in vitro , supporting the profibrogenic role of LSEC VCAM1. Conclusion VCAM1 is not just a scaffold for leukocyte adhesion during liver injury, but also a modulator of LSEC capillarization and liver fibrosis.
immunology
What problem does this paper attempt to address?